JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2005;76(Supplement 5 ):v45-v52; doi:10.1136/jnnp.2005.082149
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Flier, W M
Right arrow Articles by Scheltens, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Flier, W M
Right arrow Articles by Scheltens, P
Related Collections
Right arrow Neurology in Practice
Right arrow Other imaging techniques
Right arrow Dementia

Use of laboratory and imaging investigations in dementia

W M van der Flier, P Scheltens

Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, the Netherlands

Correspondence to:
Correspondence to:
W M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands; wm.vdflier@vumc.nl

Keywords: dementia; Alzheimer’s disease; magnetic resonance imaging

The first 150 words of the full text of this article appear below.

The diagnosis of dementia is a complicated enterprise. This is partly caused by the insidious onset of most diseases that cause dementia. The difficulty is clearly captured in the question: "Where does ageing stop and dementia begin?". The availability of symptomatic treatment (for example, acetyl cholinesterase inhibitors) and the development of new disease modifying drugs emphasises the need for improved diagnostic accuracy. Patients that are in the earliest stages of the disease may potentially profit most from disease modifying drugs. This further underlines the importance of a correct clinical diagnosis early in the course of the disease. During lifetime, with careful evaluation and the application of well defined, clinical criteria, "probable" diagnoses can be made with a relatively high level of accuracy. A definite diagnosis of Alzheimer’s disease (AD) or most other diseases that cause dementia can only be made post mortem, after necropsy.

Neuropathology accumulates gradually, and it has . . . [Full text of this article]




eLetters:

Read all eLetters

The contribution of neurophysiology in the diagnosis of dementia
Vincenzo Di Lazzaro, et al.
JNNP Online, 23 Nov 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.